Literature DB >> 11180120

Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(s).

M Kalbus1, B T Fleckenstein, M Offenhäusser, M Blüggel, A Melms, H E Meyer, H G Rammensee, R Martin, G Jung, N Sommer.   

Abstract

The MHC class II molecule H2-A(s), expressed in the SJL mouse strain, is the principle restriction element of autoreactive CD4(+) T cells mediating experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. We deduced the H2-A(s) ligand motif from the analysis of naturally processed self peptides and from peptide binding studies. Major anchor residues were identified using various sets of substituted and truncated peptides, derived from natural peptide ligands and known H2-A(s) binders like myelin basic protein 81 - 99. The nine-residue H2-A(s) core binding motif comprises an arrangement of anchors in relative positions P1, P4, P6, P7, and P9. The P1 pocket is relatively unspecific and the P6 pocket favors hydrophobic-aliphatic side chains. The P1 pocket contributes little to peptide binding. Primary anchors were identified in P4, P7, and in particular in P9. The preferred anchor residues are Lys (P4), His/Arg (P7), and Pro (P9), respectively. Ala-polysubstituted peptides containing only one of these dominant anchor residues still retain the capacity to bind to H2-A(s). Thus, the presence of only one suitable anchor side chain in P4, P7, or P9 is sufficient for high-affinity peptide binding, at least in the absence of negatively charged side chains nearby. The identified ligand motif facilitates the analysis of immunogenic peptides interacting with H2-A(s) and will allow a better prediction of pathogenetically relevant peptide antigens in the autoimmune mouse model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180120     DOI: 10.1002/1521-4141(200102)31:2<551::aid-immu551>3.0.co;2-p

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.

Authors:  Jennifer L Nayak; Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

2.  Conformational analysis of the ΜΒΡ83-99 (Phe91) and ΜΒΡ83-99 (Tyr91) peptide analogues and study of their interactions with the HLA-DR2 and human TCR receptors by using molecular dynamics.

Authors:  C Potamitis; M-T Matsoukas; T Tselios; T Mavromoustakos; S Golič Grdadolnik
Journal:  J Comput Aided Mol Des       Date:  2011-09-06       Impact factor: 3.686

3.  A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability.

Authors:  Katherine A Richards; Courtney Lavery; Grant L J Keller; Jim Miller; Brian M Baker; Andrea J Sant
Journal:  Mol Immunol       Date:  2022-01-05       Impact factor: 4.174

4.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

5.  CD4 T cell epitope specificity determines follicular versus non-follicular helper differentiation in the polyclonal response to influenza infection or vaccination.

Authors:  Zackery A G Knowlden; Andrea J Sant
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

6.  Design and Synthesis of Non-Peptide Mimetics Mapping the Immunodominant Myelin Basic Protein (MBP83-96) Epitope to Function as T-Cell Receptor Antagonists.

Authors:  Mary-Patricia Yannakakis; Carmen Simal; Haralambos Tzoupis; Maria Rodi; Narges Dargahi; Monica Prakash; Athanasia Mouzaki; James A Platts; Vasso Apostolopoulos; Theodore V Tselios
Journal:  Int J Mol Sci       Date:  2017-06-08       Impact factor: 5.923

7.  Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus.

Authors:  J Ludovic Croxford; Anne M Ercolini; Mathew Degutes; Stephen D Miller
Journal:  Eur J Immunol       Date:  2006-10       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.